Please use this identifier to cite or link to this item:
|Title:||Improvements in quality of care resulting from a formal multidisciplinary tumour clinic in the management of high-grade glioma||Authors:||Back, M.F.
|Issue Date:||May-2007||Citation:||Back, M.F., Ang, E.L.L., Ng, W.-H., See, S.-J., Tchoyoson, L.C.C., Tay, L.-L., Yeo, T.-T. (2007-05). Improvements in quality of care resulting from a formal multidisciplinary tumour clinic in the management of high-grade glioma. Annals of the Academy of Medicine Singapore 36 (5) : 347-351. ScholarBank@NUS Repository.||Abstract:||Introduction: There is increasing belief that a formal protocol-based multidisciplinary care model should be adopted as an optimal care model in oncology. However, there is minimal outcome evidence to demonstrate an improvement in patient care. The aim of this study was to compare clinical quality outcomes between patients with high-grade glioma managed at one hospital using a formal neuro-oncology multidisciplinary tumour clinic (MTC) and a second hospital with a traditional on-call referral pattern (non-MTC). Materials and Methods: Patients with high-grade glioma managed radically with radiation therapy at 2 Singapore hospitals from May 2002 to May 2006 were entered into a prospective database. Patients were grouped into management via MTC or non-MTC. Four clinical quality indicators were chosen retrospectively to assess the variation in practice: a) Use of computed tomography (CT) or magnetic resonance (MR) imaging post-resection (POI) for assessment of residual disease; b) Commencement of radiation therapy (RT) within 28 days of surgery; c) Adjuvant chemotherapy use for glioblastoma multiforme (CTGBM) and d) Median survival. Results: Sixty-seven patients were managed radically, with 47 by MTC and by 20 by non-MTC. MTC patients were more likely to have POI (P = 0.042), and CTGBM (P = 0.025). Although the RT start time was similar for the whole cohort (60% versus 45%: P = 0.296); for GBM patients, the RT start was earlier (63% vs 33% P = 0.024). The median survival for the MTC group was 18.7 months versus 11.9 months for the non-MTC group (P = 0.11). Conclusion: Clinical quality outcomes were significantly improved in patients with high-grade glioma managed in this neuro-oncology MTC.||Source Title:||Annals of the Academy of Medicine Singapore||URI:||http://scholarbank.nus.edu.sg/handle/10635/131501||ISSN:||03044602|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 21, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.